RWD15 Epidemiology Description, Treatment Patterns, Resource Utilization and Biomarker Testing of Metastatic Triple Negative Breast Cancer (TNBC) Patients in Costa Rica
This research aims to explore metastatic (stage IV) TNBC epidemiology, clinical data, biomarker use, anticancer therapy, Healthcare Resource Utilization (HCRU), cost of healthcare, and Local Burden of Disease (LBD) in adult female population within Costa Rican public health sector. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: C. Beltran, A. Rosado, M.D.L. Garcia, J. Urrego-Reyes, N. Chacin, A.M. Rendon Source Type: research
HTA31 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica
In Costa Rica, 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) are available to prevent invasive pneumococcal disease (IPD) such as meningitis, bacteremia, as well as community-acquired pneumococcal pneumonia (CAP) caused by serotypes contained in these vaccines. This analysis estimated the clinical and economic values of PCV13 and PPSV23 from the public healthcare perspective. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: J. Ordo ñez, J.J. Baldi Castro Source Type: research
EE471 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Costa Rica from the Public Health System Perspective
To estimate the cost-effectiveness of the screening strategy with the molecular test with genotyping 16/18 compared to conventional cytology for the detection of human papilloma virus infection in Costa Rica. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: N. Armijo, T. Abbott, F. Vera, P. Zamorano, C. Balmaceda, M.A. Espinoza, A. Calderon Source Type: research
EE419 Budget Impact Analysis of Faricimab for treating patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Costa Rica
Diabetic Macular Edema (DME) and neovascular Age-related Macular Degeneration (nAMD) cause vision loss leading to loss of health-related quality of life. Faricimab is a bispecific antibody that binds and inhibits both VEGF-A and angiopoietin-2. The aim is to estimate the budget impact (BI) of using Faricimab in Costa Rica's healthcare system. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: J. Hidalgo, J. Ordo ñez, M. Salas, L. Wu, R. Acevedo, J.C. Gutierrez Source Type: research
EE306 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Costa Rica
Diabetic Macular Edema (DME) and neovascular Age-related Macular Degeneration (nAMD) cause vision loss leading to morbidity and loss of health-related quality of life. Treatment in the country is based on laser and anti-vascular endothelial growth factor (VEGF). Our objective is to estimate the economic burden generated by these diseases in Costa Rica to have information that allows decision-makers to estimate the magnitude of this problem in the country. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: J. Hidalgo, J. Ordo ñez, M. Salas, L. Wu, R. Acevedo, J.C. Gutierrez Source Type: research
EE96 Budget Impact Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica
In Costa Rica, the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) are available to prevent invasive pneumococcal disease (IPD) such as meningitis, bacteremia, as well as community-acquired pneumococcal pneumonia (CAP) caused by serotypes contained in these vaccines. We aim to estimate these vaccines' budget impact (BI) on Costa Rica's public health system. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: J. Ordo ñez, J.J. Baldi astro Source Type: research
Understanding the role of personal experiences and contextual variables in shaping risk reduction preferences
This article explores how preferences for risk reduction during the COVID-19 pandemic are influenced by personal experiences and contextual variables such as having a close friend or relative who has been infected by the virus (closeness), the severity of the illness (severity), people's own perceptions of being in a risky group (risk group), change in employment status due to the pandemic (employment situation), and vaccination status (vaccination status and altruistic vaccination). We conducted a choice experiment (CE) in Chile, Colombia, and Costa Rica. The attributes of the experiment were risk reduction, latency, and ...
Source: Vaccine - May 31, 2023 Category: Allergy & Immunology Authors: Manuel Barrientos Felipe V ásquez-Lavin Constanza Rosales Luna Bratti Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: The American Journal of Tropical Medicine and Hygiene)
Source: The American Journal of Tropical Medicine and Hygiene - May 30, 2023 Category: Tropical Medicine Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: Am J Trop Med Hyg)
Source: Am J Trop Med Hyg - May 30, 2023 Category: Infectious Diseases Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: The American Journal of Tropical Medicine and Hygiene)
Source: The American Journal of Tropical Medicine and Hygiene - May 30, 2023 Category: Tropical Medicine Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: Am J Trop Med Hyg)
Source: Am J Trop Med Hyg - May 30, 2023 Category: Infectious Diseases Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: The American Journal of Tropical Medicine and Hygiene)
Source: The American Journal of Tropical Medicine and Hygiene - May 30, 2023 Category: Tropical Medicine Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: Am J Trop Med Hyg)
Source: Am J Trop Med Hyg - May 30, 2023 Category: Infectious Diseases Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: The American Journal of Tropical Medicine and Hygiene)
Source: The American Journal of Tropical Medicine and Hygiene - May 30, 2023 Category: Tropical Medicine Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
Detection of Human Paragonimiasis by ELISA Using Recombinant Paragonimus westermani Cysteine Protease 7
This report is the first to describe the development of an ELISA for the diagnosis of Paragonimus spp. in Costa Rica and Central America. Using this ELISA in the health system of Costa Rica is recommended to detect infections.PMID:37253437 | DOI:10.4269/ajtmh.22-0452 (Source: Am J Trop Med Hyg)
Source: Am J Trop Med Hyg - May 30, 2023 Category: Infectious Diseases Authors: Luana Gabriele Andrade-Gomes Mar ía J Zuniga Gaby Dolz Frank Solano-Campos Source Type: research
